Inserm Institut National De La Sant Et De La Recherche Mdicale competitive analysis

Latest publications and patents of Inserm Institut National De La Sant Et De La Recherche Mdicale New

Explore the latest publications and patents granted to Inserm Institut National De La Sant Et De La Recherche Mdicale, showcasing their recent innovations and technological advancements.

Last updated on: Sep 23, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Inserm Institut National De La Sant Et De La Recherche Mdicale

Apr 3, 2024Aav-Mediated Gene Therapy Restoring The Otoferlin GeneGranted And Under Opposition
Nov 8, 2023New Alzheimer'S Disease Animal ModelPatent Maintained As Amended
Oct 4, 2023Il-15 And Il-15Ralpha Sushi Domain Based On ModulokinesGranted And Under Opposition
Oct 12, 2022Compositions And Methods For Increasing Or Enhancing Transduction Of Gene Therapy Vectors And For Removing Or Reducing ImmunoglobulinsGranted And Under Opposition
May 4, 2022Use Of A Laminin For Differentiating Pluripotent Cells Into Hepatocyte Lineage CellsPatent Maintained As Amended
Aug 11, 2021Methods And Pharmaceutical Compositions For Expressing A Polynucleotide Of Interest In The Peripheral Nervous System Of A SubjectGranted And Under Opposition
Jan 20, 2021Use Of A Reverse-Transcriptase Inhibitor In The Prevention And Treatment Of Degenerative DiseasesGranted And Under Opposition
Dec 9, 2020Recombinant Adeno-Associated Virus Particle Purification With Multiple-Step Anion Exchange ChromatographyGranted And Under Opposition
Nov 25, 2020Recombinant Adeno-Associated Virus Particle Purification Comprising An Affinity Purification StepGranted And Under Opposition
Sep 23, 2020Antibodies Against Human Cd39 And Use Thereof For Inhibiting T Regulatory Cells ActivityGranted And Under Opposition

Explore Inserm Institut National De La Sant Et De La Recherche Mdicale's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 25, 2025
Patent NumberGrant DateTitleTotal Oppositions
Apr 3, 2024Aav-Mediated Gene Therapy Restoring The Otoferlin Gene4
Nov 8, 2023New Alzheimer'S Disease Animal Model1
Oct 4, 2023Il-15 And Il-15Ralpha Sushi Domain Based On Modulokines1
Oct 12, 2022Compositions And Methods For Increasing Or Enhancing Transduction Of Gene Therapy Vectors And For Removing Or Reducing Immunoglobulins6
May 4, 2022Use Of A Laminin For Differentiating Pluripotent Cells Into Hepatocyte Lineage Cells1
Aug 11, 2021Methods And Pharmaceutical Compositions For Expressing A Polynucleotide Of Interest In The Peripheral Nervous System Of A Subject1
Jan 20, 2021Use Of A Reverse-Transcriptase Inhibitor In The Prevention And Treatment Of Degenerative Diseases1
Dec 9, 2020Recombinant Adeno-Associated Virus Particle Purification With Multiple-Step Anion Exchange Chromatography1
Nov 25, 2020Recombinant Adeno-Associated Virus Particle Purification Comprising An Affinity Purification Step7
Sep 23, 2020Antibodies Against Human Cd39 And Use Thereof For Inhibiting T Regulatory Cells Activity4

Latest PTAB cases involving Inserm Institut National De La Sant Et De La Recherche Mdicale

Discover the latest PTAB cases involving Inserm Institut National De La Sant Et De La Recherche Mdicale, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Inserm Institut National De La Sant Et De La Recherche Mdicale with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 25, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
INSERM INSTITUT NATIONAL DE LA SANT ET DE LA RECHERCHE MDICALE - 35 - - Non-Active
MICHALSKI HUTTERMANN & PARTNER PATENTANWALTE MBB26 - - - Highly Aggressive
SANOFI5923 - - Highly Aggressive
STRAWMAN329 - - - Highly Aggressive